SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care Diagnostics

In this study, the intrinsic surface-enhanced Raman spectroscopy (SERS)-based approach coupled with chemometric analysis was adopted to establish the biochemical fingerprint of SARS-CoV-2 infected human fluids: saliva and nasopharyngeal swabs. The numerical methods, partial least squares discriminan...

Full description

Bibliographic Details
Main Authors: Sylwia M. Berus, Ariadna B. Nowicka, Julia Wieruszewska, Krzysztof Niciński, Aneta A. Kowalska, Tomasz R. Szymborski, Izabela Dróżdż, Maciej Borowiec, Jacek Waluk, Agnieszka Kamińska
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/11/9706
_version_ 1797597348289839104
author Sylwia M. Berus
Ariadna B. Nowicka
Julia Wieruszewska
Krzysztof Niciński
Aneta A. Kowalska
Tomasz R. Szymborski
Izabela Dróżdż
Maciej Borowiec
Jacek Waluk
Agnieszka Kamińska
author_facet Sylwia M. Berus
Ariadna B. Nowicka
Julia Wieruszewska
Krzysztof Niciński
Aneta A. Kowalska
Tomasz R. Szymborski
Izabela Dróżdż
Maciej Borowiec
Jacek Waluk
Agnieszka Kamińska
author_sort Sylwia M. Berus
collection DOAJ
description In this study, the intrinsic surface-enhanced Raman spectroscopy (SERS)-based approach coupled with chemometric analysis was adopted to establish the biochemical fingerprint of SARS-CoV-2 infected human fluids: saliva and nasopharyngeal swabs. The numerical methods, partial least squares discriminant analysis (PLS-DA) and support vector machine classification (SVMC), facilitated the spectroscopic identification of the viral-specific molecules, molecular changes, and distinct physiological signatures of pathetically altered fluids. Next, we developed the reliable classification model for fast identification and differentiation of negative CoV(−) and positive CoV(+) groups. The PLS-DA calibration model was described by a great statistical value—RMSEC and RMSECV below 0.3 and R<sup>2</sup><sub>cal</sub> at the level of ~0.7 for both type of body fluids. The calculated diagnostic parameters for SVMC and PLS-DA at the stage of preparation of calibration model and classification of external samples simulating real diagnostic conditions evinced high accuracy, sensitivity, and specificity for saliva specimens. Here, we outlined the significant role of neopterin as the biomarker in the prediction of COVID-19 infection from nasopharyngeal swab. We also observed the increased content of nucleic acids of DNA/RNA and proteins such as ferritin as well as specific immunoglobulins. The developed SERS for SARS-CoV-2 approach allows: (i) fast, simple and non-invasive collection of analyzed specimens; (ii) fast response with the time of analysis below 15 min, and (iii) sensitive and reliable SERS-based screening of COVID-19 disease.
first_indexed 2024-03-11T03:04:58Z
format Article
id doaj.art-c0d59a785d57468ea15c78b751e3cca6
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T03:04:58Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c0d59a785d57468ea15c78b751e3cca62023-11-18T08:02:53ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-06-012411970610.3390/ijms24119706SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care DiagnosticsSylwia M. Berus0Ariadna B. Nowicka1Julia Wieruszewska2Krzysztof Niciński3Aneta A. Kowalska4Tomasz R. Szymborski5Izabela Dróżdż6Maciej Borowiec7Jacek Waluk8Agnieszka Kamińska9Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, PolandInstitute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, PolandInstitute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, PolandInstitute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, PolandInstitute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, PolandInstitute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, PolandDepartment of Clinical Genetics, Medical University of Łódź, Pomorska 251, 92-213 Łódź, PolandDepartment of Clinical Genetics, Medical University of Łódź, Pomorska 251, 92-213 Łódź, PolandInstitute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, PolandInstitute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, PolandIn this study, the intrinsic surface-enhanced Raman spectroscopy (SERS)-based approach coupled with chemometric analysis was adopted to establish the biochemical fingerprint of SARS-CoV-2 infected human fluids: saliva and nasopharyngeal swabs. The numerical methods, partial least squares discriminant analysis (PLS-DA) and support vector machine classification (SVMC), facilitated the spectroscopic identification of the viral-specific molecules, molecular changes, and distinct physiological signatures of pathetically altered fluids. Next, we developed the reliable classification model for fast identification and differentiation of negative CoV(−) and positive CoV(+) groups. The PLS-DA calibration model was described by a great statistical value—RMSEC and RMSECV below 0.3 and R<sup>2</sup><sub>cal</sub> at the level of ~0.7 for both type of body fluids. The calculated diagnostic parameters for SVMC and PLS-DA at the stage of preparation of calibration model and classification of external samples simulating real diagnostic conditions evinced high accuracy, sensitivity, and specificity for saliva specimens. Here, we outlined the significant role of neopterin as the biomarker in the prediction of COVID-19 infection from nasopharyngeal swab. We also observed the increased content of nucleic acids of DNA/RNA and proteins such as ferritin as well as specific immunoglobulins. The developed SERS for SARS-CoV-2 approach allows: (i) fast, simple and non-invasive collection of analyzed specimens; (ii) fast response with the time of analysis below 15 min, and (iii) sensitive and reliable SERS-based screening of COVID-19 disease.https://www.mdpi.com/1422-0067/24/11/9706SARS-CoV-2salivanasopharyngeal swabssurface-enhanced Raman spectroscopychemometric analysis
spellingShingle Sylwia M. Berus
Ariadna B. Nowicka
Julia Wieruszewska
Krzysztof Niciński
Aneta A. Kowalska
Tomasz R. Szymborski
Izabela Dróżdż
Maciej Borowiec
Jacek Waluk
Agnieszka Kamińska
SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care Diagnostics
International Journal of Molecular Sciences
SARS-CoV-2
saliva
nasopharyngeal swabs
surface-enhanced Raman spectroscopy
chemometric analysis
title SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care Diagnostics
title_full SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care Diagnostics
title_fullStr SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care Diagnostics
title_full_unstemmed SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care Diagnostics
title_short SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care Diagnostics
title_sort sers signature of sars cov 2 in saliva and nasopharyngeal swabs towards perspective covid 19 point of care diagnostics
topic SARS-CoV-2
saliva
nasopharyngeal swabs
surface-enhanced Raman spectroscopy
chemometric analysis
url https://www.mdpi.com/1422-0067/24/11/9706
work_keys_str_mv AT sylwiamberus serssignatureofsarscov2insalivaandnasopharyngealswabstowardsperspectivecovid19pointofcarediagnostics
AT ariadnabnowicka serssignatureofsarscov2insalivaandnasopharyngealswabstowardsperspectivecovid19pointofcarediagnostics
AT juliawieruszewska serssignatureofsarscov2insalivaandnasopharyngealswabstowardsperspectivecovid19pointofcarediagnostics
AT krzysztofnicinski serssignatureofsarscov2insalivaandnasopharyngealswabstowardsperspectivecovid19pointofcarediagnostics
AT anetaakowalska serssignatureofsarscov2insalivaandnasopharyngealswabstowardsperspectivecovid19pointofcarediagnostics
AT tomaszrszymborski serssignatureofsarscov2insalivaandnasopharyngealswabstowardsperspectivecovid19pointofcarediagnostics
AT izabeladrozdz serssignatureofsarscov2insalivaandnasopharyngealswabstowardsperspectivecovid19pointofcarediagnostics
AT maciejborowiec serssignatureofsarscov2insalivaandnasopharyngealswabstowardsperspectivecovid19pointofcarediagnostics
AT jacekwaluk serssignatureofsarscov2insalivaandnasopharyngealswabstowardsperspectivecovid19pointofcarediagnostics
AT agnieszkakaminska serssignatureofsarscov2insalivaandnasopharyngealswabstowardsperspectivecovid19pointofcarediagnostics